Cargando…

Chronic Allopurinol Treatment during the Last Trimester of Pregnancy in Sows: Effects on Low and Normal Birth Weight Offspring

Low-birth-weight (LBW) children are born with several risk factors for disease, morbidity and neonatal mortality, even if carried to term. Placental insufficiency leading to hypoxemia and reduced nutritional supply is the main cause for LBW. Brain damage and poor neurological outcome can be the cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Gieling, Elise T., Antonides, Alexandra, Fink-Gremmels, Johanna, ter Haar, Kim, Kuller, Wikke I., Meijer, Ellen, Nordquist, Rebecca E., Stouten, Jacomijn M., Zeinstra, Elly, van der Staay, Franz Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899238/
https://www.ncbi.nlm.nih.gov/pubmed/24466072
http://dx.doi.org/10.1371/journal.pone.0086396
_version_ 1782300541013983232
author Gieling, Elise T.
Antonides, Alexandra
Fink-Gremmels, Johanna
ter Haar, Kim
Kuller, Wikke I.
Meijer, Ellen
Nordquist, Rebecca E.
Stouten, Jacomijn M.
Zeinstra, Elly
van der Staay, Franz Josef
author_facet Gieling, Elise T.
Antonides, Alexandra
Fink-Gremmels, Johanna
ter Haar, Kim
Kuller, Wikke I.
Meijer, Ellen
Nordquist, Rebecca E.
Stouten, Jacomijn M.
Zeinstra, Elly
van der Staay, Franz Josef
author_sort Gieling, Elise T.
collection PubMed
description Low-birth-weight (LBW) children are born with several risk factors for disease, morbidity and neonatal mortality, even if carried to term. Placental insufficiency leading to hypoxemia and reduced nutritional supply is the main cause for LBW. Brain damage and poor neurological outcome can be the consequence. LBW after being carried to term gives better chances for survival, but these children are still at risk for poor health and the development of cognitive impairments. Preventive therapies are not yet available. We studied the risk/efficacy of chronic prenatal treatment with the anti-oxidative drug allopurinol, as putative preventive treatment in piglets. LBW piglets served as a natural model for LBW. A cognitive holeboard test was applied to study the learning and memory abilities of these allopurinol treated piglets after weaning. Preliminary analysis of the plasma concentrations in sows and their piglets suggested that a daily dose of 15 mg.kg(−1) resulted in effective plasma concentration of allopurinol in piglets. No adverse effects of chronic allopurinol treatment were found on farrowing, birth weight, open field behavior, learning abilities, relative brain, hippocampus and spleen weights. LBW piglets showed increased anxiety levels in an open field test, but cognitive performance was not affected by allopurinol treatment. LBW animals treated with allopurinol showed the largest postnatal compensatory body weight gain. In contrast to a previous study, no differences in learning abilities were found between LBW and normal-birth-weight piglets. This discrepancy might be attributable to experimental differences. Our results indicate that chronic prenatal allopurinol treatment during the third trimester of pregnancy is safe, as no adverse side effects were observed. Compensatory weight gain of treated piglets is a positive indication for the chronic prenatal use of allopurinol in these animals. Further studies are needed to assess the possible preventive effects of allopurinol on brain functions in LBW piglets.
format Online
Article
Text
id pubmed-3899238
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38992382014-01-24 Chronic Allopurinol Treatment during the Last Trimester of Pregnancy in Sows: Effects on Low and Normal Birth Weight Offspring Gieling, Elise T. Antonides, Alexandra Fink-Gremmels, Johanna ter Haar, Kim Kuller, Wikke I. Meijer, Ellen Nordquist, Rebecca E. Stouten, Jacomijn M. Zeinstra, Elly van der Staay, Franz Josef PLoS One Research Article Low-birth-weight (LBW) children are born with several risk factors for disease, morbidity and neonatal mortality, even if carried to term. Placental insufficiency leading to hypoxemia and reduced nutritional supply is the main cause for LBW. Brain damage and poor neurological outcome can be the consequence. LBW after being carried to term gives better chances for survival, but these children are still at risk for poor health and the development of cognitive impairments. Preventive therapies are not yet available. We studied the risk/efficacy of chronic prenatal treatment with the anti-oxidative drug allopurinol, as putative preventive treatment in piglets. LBW piglets served as a natural model for LBW. A cognitive holeboard test was applied to study the learning and memory abilities of these allopurinol treated piglets after weaning. Preliminary analysis of the plasma concentrations in sows and their piglets suggested that a daily dose of 15 mg.kg(−1) resulted in effective plasma concentration of allopurinol in piglets. No adverse effects of chronic allopurinol treatment were found on farrowing, birth weight, open field behavior, learning abilities, relative brain, hippocampus and spleen weights. LBW piglets showed increased anxiety levels in an open field test, but cognitive performance was not affected by allopurinol treatment. LBW animals treated with allopurinol showed the largest postnatal compensatory body weight gain. In contrast to a previous study, no differences in learning abilities were found between LBW and normal-birth-weight piglets. This discrepancy might be attributable to experimental differences. Our results indicate that chronic prenatal allopurinol treatment during the third trimester of pregnancy is safe, as no adverse side effects were observed. Compensatory weight gain of treated piglets is a positive indication for the chronic prenatal use of allopurinol in these animals. Further studies are needed to assess the possible preventive effects of allopurinol on brain functions in LBW piglets. Public Library of Science 2014-01-22 /pmc/articles/PMC3899238/ /pubmed/24466072 http://dx.doi.org/10.1371/journal.pone.0086396 Text en © 2014 Gieling et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gieling, Elise T.
Antonides, Alexandra
Fink-Gremmels, Johanna
ter Haar, Kim
Kuller, Wikke I.
Meijer, Ellen
Nordquist, Rebecca E.
Stouten, Jacomijn M.
Zeinstra, Elly
van der Staay, Franz Josef
Chronic Allopurinol Treatment during the Last Trimester of Pregnancy in Sows: Effects on Low and Normal Birth Weight Offspring
title Chronic Allopurinol Treatment during the Last Trimester of Pregnancy in Sows: Effects on Low and Normal Birth Weight Offspring
title_full Chronic Allopurinol Treatment during the Last Trimester of Pregnancy in Sows: Effects on Low and Normal Birth Weight Offspring
title_fullStr Chronic Allopurinol Treatment during the Last Trimester of Pregnancy in Sows: Effects on Low and Normal Birth Weight Offspring
title_full_unstemmed Chronic Allopurinol Treatment during the Last Trimester of Pregnancy in Sows: Effects on Low and Normal Birth Weight Offspring
title_short Chronic Allopurinol Treatment during the Last Trimester of Pregnancy in Sows: Effects on Low and Normal Birth Weight Offspring
title_sort chronic allopurinol treatment during the last trimester of pregnancy in sows: effects on low and normal birth weight offspring
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899238/
https://www.ncbi.nlm.nih.gov/pubmed/24466072
http://dx.doi.org/10.1371/journal.pone.0086396
work_keys_str_mv AT gielingeliset chronicallopurinoltreatmentduringthelasttrimesterofpregnancyinsowseffectsonlowandnormalbirthweightoffspring
AT antonidesalexandra chronicallopurinoltreatmentduringthelasttrimesterofpregnancyinsowseffectsonlowandnormalbirthweightoffspring
AT finkgremmelsjohanna chronicallopurinoltreatmentduringthelasttrimesterofpregnancyinsowseffectsonlowandnormalbirthweightoffspring
AT terhaarkim chronicallopurinoltreatmentduringthelasttrimesterofpregnancyinsowseffectsonlowandnormalbirthweightoffspring
AT kullerwikkei chronicallopurinoltreatmentduringthelasttrimesterofpregnancyinsowseffectsonlowandnormalbirthweightoffspring
AT meijerellen chronicallopurinoltreatmentduringthelasttrimesterofpregnancyinsowseffectsonlowandnormalbirthweightoffspring
AT nordquistrebeccae chronicallopurinoltreatmentduringthelasttrimesterofpregnancyinsowseffectsonlowandnormalbirthweightoffspring
AT stoutenjacomijnm chronicallopurinoltreatmentduringthelasttrimesterofpregnancyinsowseffectsonlowandnormalbirthweightoffspring
AT zeinstraelly chronicallopurinoltreatmentduringthelasttrimesterofpregnancyinsowseffectsonlowandnormalbirthweightoffspring
AT vanderstaayfranzjosef chronicallopurinoltreatmentduringthelasttrimesterofpregnancyinsowseffectsonlowandnormalbirthweightoffspring